Weโre proud to share that ๐๐๐ซ๐ฅ๐ฒ๐๐ข๐ ๐ก๐ญ has been ranked among theโฏ๐๐จ๐ฉ 100 ๐๐ฐ๐ข๐ฌ๐ฌ ๐๐ญ๐๐ซ๐ญ-๐ฎ๐ฉ๐ฌ ๐จ๐ 2024, placingโฏ6๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ ๐๐๐๐๐๐๐ก ๐๐๐ญ๐๐ ๐จ๐ซ๐ฒ andโฏ48๐ญ๐ก ๐จ๐ฏ๐๐ซ๐๐ฅ๐ฅ! ๐
๐โฏ๐๐ก๐ฒ ๐๐๐ซ๐ฅ๐ฒ๐๐ข๐ ๐ก๐ญ ๐๐จ๐ง๐ฏ๐ข๐ง๐๐๐ ๐ญ๐ก๐ ๐ฃ๐ฎ๐ซ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ฒ๐๐๐ซ?
Our mission is clear:โฏ๐ญ๐ซ๐๐ง๐ฌ๐๐จ๐ซ๐ฆ ๐ญ๐ก๐ ๐๐๐ซ๐ฅ๐ฒ ๐๐๐ญ๐๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ฒ๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌโฏthrough unparalleled imaging technology. In April 2023, we launched production of our flagship product,โฏ๐๐๐ฅ๐ฅ๐ฎ๐ฅ๐๐ซ๐ข๐ฌโฏ๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ๐ฒ, which sold out in its first run! ๐ This advanced retinal camera offersโฏ๐ญ๐๐ง๐๐จ๐ฅ๐ ๐ข๐ฆ๐๐ ๐ ๐ซ๐๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐งโฏcompared to current standards, and we are the only company with patentedโฏ๐๐๐๐ฉ๐ญ๐ข๐ฏ๐ ๐๐ฉ๐ญ๐ข๐๐ฌ ๐๐ซ๐๐ง๐ฌ๐ฌ๐๐ฅ๐๐ซ๐๐ฅ ๐ ๐ฅ๐จ๐จ๐ ๐๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐๐ญ๐ข๐จ๐ง (๐๐-๐๐ ๐) technology, allowing unprecedented observation of RPE cells.
๐กโฏ๐๐๐ฒ ๐๐๐ก๐ข๐๐ฏ๐๐ฆ๐๐ง๐ญ๐ฌ:
๐ A dedicated ๐ญ๐๐๐ฆย that delivers, overcoming the challenges of a start-up.
๐ Overโฏ600 ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌโฏhave been examined using our technology, yielding invaluable insights into retinal pathologies.
๐ Exciting new collaborations with pharma companies who see cellular-resolution imaging as essential for developing ๐ญ๐ก๐โฏ๐ง๐๐ฑ๐ญ ๐ ๐๐ง๐๐ซ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ.
Thank you to our amazing team, partnersโฏand customers for believing in our vision and helping us reach new heights. Weโre excited for whatโs next!
Theโฏ๐๐จ๐ฉ 100 ๐๐ฐ๐ข๐ฌ๐ฌ ๐๐ญ๐๐ซ๐ญ-๐ฎ๐ฉ ๐๐ฐ๐๐ซ๐โฏis a benchmark event, highlighting Switzerlandโs most promising and innovative ventures. Over the past decade, 553โฏdeep-techโฏstart-ups have featured in the ranking, creating nearly 19,000 jobs and raising over CHF 13.6 billion. Weโreโฏhonouredโฏto be part of this incredible community, recognized by a jury of investors, successful entrepreneurs, and key ecosystem stakeholders.
